CRMD CorMedix Inc. - Common Stock
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$7,19
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$6,13minimo 52 sett.
$13,02massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$558M
P/E (TTM)
3.3
EPS (TTM)
$2.18
Ricavi (TTM)
$462M
i tuoi badge
Intervallo 52 sett.
$6–$13
Rating Analisti
BUY
Prezzo Obiettivo
$15
P/E
3.3
ROE
54.9%
Margine di Profitto Netto
40.5%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
CRMD Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$7.19
Capitalizzazione di Mercato (MRQ)
$558M
P/E (TTM)
3.3
EPS (TTM)
$2.18
Ricavi (TTM)
$462M
ROE (TTM)
54.9%
Intervallo 52 sett.
$6–$13
CRMD Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 26 Marzo 2019 | 1-for-5 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$312M2016-12-31 → 2025-12-31
EPS$2.042021-12-31 → 2025-12-31
Flusso di cassa libero$173M2016-12-31 → 2025-12-31
Margine netto40.5%2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | CRMD | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E (TTM) | 3.3media 5 anni ≈-7.4 | ≈-7.4 | 29.2 | Sottovalutato | |
| P/S (TTM) | 1.2media 5 anni ≈1296.8 | ≈1296.8 | 4.9 | Sottovalutato | |
| P/B (MRQ) | 1.2media 5 anni ≈3.5 | ≈3.5 | 3.8 | Sottovalutato | |
| Prezzo / FCF (TTM) | 2.2media 5 anni ≈-5.1 | ≈-5.1 | · | · | |
| Prezzo / Flusso di cassa (TTM) | 2.2media 5 anni ≈-5.2 | ≈-5.2 | · | · | |
| Prezzo / Valore contabile tangibile (MRQ) | 5.5media 5 anni ≈3.8 | ≈3.8 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | CRMD | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Margine lordo (TTM) | 82.8%media 5 anni ≈74.4% | ≈74.4% | · | · | |
| Margine Operativo (TTM) | 47.0%media 5 anni ≈-15560.2% | ≈-15560.2% | -1.8% | Di prim'ordine | |
| EBITDA Margin (Margine EBITDA) | 48.2%media 5 anni ≈-15560.2% | ≈-15560.2% | 1.8% | Di prim'ordine | |
| Margine ante imposte (TTM) | 44.0%media 5 anni ≈-15432.8% | ≈-15432.8% | 12.8% | Di prim'ordine | |
| Margine di Profitto Netto (TTM) | 40.5%media 5 anni ≈-15043.4% | ≈-15043.4% | -7.5% | Di prim'ordine | |
| ROA (TTM) | 32.4%media 5 anni ≈-28.1% | ≈-28.1% | -14.9% | Di prim'ordine | |
| ROE (TTM) | 54.9%media 5 anni ≈-25.9% | ≈-25.9% | 51.1% | In linea | |
| ROIC | 40.3%media 5 anni ≈-20.9% | ≈-20.9% | 40.3% | In linea |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | CRMD | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 2.6media 5 anni ≈6.9 | ≈6.9 | 4.3 | Bassa liquidità | |
| Quick Ratio (MRQ) | 2.2media 5 anni ≈6.6 | ≈6.6 | 2.6 | In linea |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | CRMD | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 617.0%media 5 anni ≈177.0% | ≈177.0% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 1582.8% | · | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 319.8% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | CRMD | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.7media 5 anni ≈0.3 | ≈0.3 | 0.5 | Di prim'ordine | |
| Inventory Turnover (Rotazione delle scorte) | 1.2media 5 anni ≈1.3 | ≈1.3 | 1.2 | In linea | |
| Receivables Turnover (Rotazione dei crediti) | 2.8 | · | 3.5 | Debole | |
| Revenue / Employee (Ricavi / Dipendente) | ≈$1.6M | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
22.3%
Prossimo report
Nov 10, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $0.29 | $0.24 | 19.4% |
| 31 Marzo 2026 | Mag 14, 2026 | $0.49 | $0.37 | 31.7% |
| 31 Dicembre 2025 | $0.16 | $0.83 | -80.8% | |
| 30 Settembre 2025 | $1.26 | $0.66 | 91.5% | |
| 30 Giugno 2025 | $0.28 | $0.18 | 58.8% | |
| 31 Marzo 2025 | $0.30 | $0.27 | 13.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $312M | $43M | · | $65.4K | $190.9K | $239.2K | $283.3K | $429.8K | $329.3K | $224.1K | $210.1K | $189.3K | |
| Cost of Revenue | $22M | $3M | · | $3.7K | $148.9K | $204.8K | $373.2K | $396.8K | $115.0K | $366.7K | $-318.7K | $-445.8K | |
| Gross Profit | $276M | $40M | · | $61.7K | $42.0K | $34.4K | $-90.0K | $33.0K | $214.4K | $-142.6K | $-108.6K | $-256.5K | |
| R&D Expense | $19M | $4M | $13M | $11M | $13M | $13M | $11M | $19M | $24M | $16M | $6M | $1M | |
| SG&A Expense | $68M | $30M | $18M | $20M | $16M | $14M | $10M | $8M | $9M | $9M | $10M | $7M | |
| Operating Expenses | $126M | $63M | $49M | $31M | $29M | $27M | $21M | $27M | $33M | $25M | $17M | $9M | |
| Operating Income | $150M | $-22M | $-49M | $-31M | $-29M | $-27M | $-21M | $-27M | $-33M | $-25M | $-17M | $-9M | |
| Interest Expense | · | · | $34.3K | $26.5K | $15.9K | $33.2K | $787.5K | $1.9K | $5.6K | $1.3K | $4.0K | $2.1K | |
| Interest Income | $4M | $3M | $3M | · | · | $116.1K | $322.7K | $36.6K | $110.7K | $126.8K | $60.4K | $2.7K | |
| Other Non-op | $-125.0K | $3M | $3M | $336.6K | $-22.8K | $23.7K | $-486.0K | $34.6K | $-85.8K | · | · | · | |
| Pretax Income | $150M | $-19M | $-46M | $-30M | $-29M | $-27M | $-21M | $-27M | $-33M | $-25M | $-18M | $-20M | |
| Income Tax | $-13M | $-1M | · | $-585.6K | $-1M | $-5M | $-5M | · | · | · | · | · | |
| Net Income | $163M | $-18M | $-46M | $-30M | $-28M | $-22M | $-16M | $-27M | $-33M | $-25M | $-18M | $-20M | |
| EPS (Basic) | $2.25 | $-0.30 | $-0.91 | $-0.74 | $-0.75 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $2.04 | $-0.30 | $-0.91 | $-0.74 | $-0.75 | · | · | · | · | · | · | · | |
| Shares (Basic) | 72,034 | 58,872 | 50,902,931 | 40,274,273 | 37,666,081 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 80,308 | 58,872 | 50,902,931 | 40,274,273 | 37,666,081 | · | · | · | · | · | · | · | |
| EBITDA | $150M | $-22M | $-49M | $-31M | $-29M | $-27M | $-21M | $-27M | · | $-25M | · | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $145M | $41M | $44M | $43M | $53M | $42M | $16M | $18M | $10M | $8M | $12M | $4M | |
| Short-term Investments | $4M | $11M | $32M | $16M | $12M | $4M | $12M | · | $2M | $12M | $24M | $0 | |
| Receivables | $171M | $52M | · | · | · | · | · | $10.9K | $64.1K | $12.0K | $315.8K | $80.2K | |
| Inventory | $30M | $8M | $2M | · | $3.0K | $143.6K | $338.5K | $428.5K | $594.2K | $166.7K | $376.6K | $463.0K | |
| Prepaid Expense | $18M | $4M | $882.2K | $623.7K | $770.5K | $1M | $446.4K | $422.2K | $367.2K | $372.1K | $379.0K | $155.2K | |
| Current Assets | $367M | $115M | $79M | $60M | $66M | $48M | $29M | $19M | $13M | $22M | $37M | $5M | |
| PP&E (Net) | $6M | $2M | $2M | $2M | $1M | $111.5K | $122.1K | $160.9K | $186.3K | $69.7K | $37.9K | $41.5K | |
| PP&E (Gross) | · | · | $2M | $2M | $1M | $111.5K | · | · | · | · | · | · | |
| Accum. Depreciation | · | $674.0K | $521.0K | · | · | · | $244.3K | $218.9K | $154.8K | · | · | · | |
| Goodwill | $30M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $379M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $826M | $119M | $82M | $62M | $69M | $49M | $29M | $19M | $13M | $22M | $37M | $5M | |
| Accounts Payable | $8M | $2M | $4M | $2M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $893.4K | |
| Accrued Liabilities | $163M | $32M | $7M | $4M | $3M | $3M | $5M | $5M | $4M | $2M | $1M | $521.5K | |
| Current Liabilities | $174M | $34M | $11M | $6M | $5M | $4M | $6M | $8M | $6M | $4M | $3M | $1M | |
| Capital Leases | $2M | $349.0K | $517.0K | $667.6K | $802.4K | $923.7K | $2.7K | · | · | · | · | · | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $421M | $34M | $12M | $7M | $6M | $5M | $6M | $14M | $6M | $4M | $3M | $1M | |
| Common Stock | $79.0K | $64.0K | $54.9K | $42.8K | $38.1K | $33.6K | $25.7K | $21.8K | $71.4K | $40.4K | $36.0K | $22.5K | |
| Paid-in Capital | $582M | $424M | $392M | $330M | $308M | $262M | $219M | $184M | $159M | · | · | · | |
| Retained Earnings | $-177M | $-340M | $-322M | $-275M | $-246M | $-217M | $-195M | $-179M | $-152M | $-119M | $-94M | $-76M | |
| AOCI | $3.0K | $91.0K | $94.1K | $82.7K | $87.1K | $102.0K | $97.3K | $96.5K | $98.4K | $81.2K | $62.1K | $99.0K | |
| Stockholders' Equity | $405M | $85M | $70M | $55M | $63M | $44M | $24M | $5M | $7M | $18M | $34M | $4M | |
| Liabilities + Equity | $826M | $119M | $82M | $62M | $69M | $49M | $29M | $19M | $13M | $22M | $37M | $5M | |
| Shares Outstanding | 79,260,667 | 64,411,000 | 54,938,258 | 42,815,196 | 38,086,437 | 33,558,096 | 25,665,350 | 21,775,173 | 71,413,790 | 40,432,339 | 35,963,348 | 22,461,668 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $6M | $5M | $4M | $5M | $2M | $2M | $1M | $2M | $1M | $3M | $2M | |
| Deferred Tax | $-26M | · | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $14M | $156.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $175M | $-51M | $-38M | $-24M | $-21M | $-22M | $-15M | $-24M | $-29M | $-22M | $-13M | $-6M | |
| CapEx | $2M | $116.0K | $327.3K | $219.4K | $1M | $112.6K | $36.6K | $48.9K | $152.0K | $58.7K | $15.4K | $25.4K | |
| Investing Cash Flow | $-308M | $21M | $-17M | $-4M | $-9M | $7M | $-12M | $2M | $10M | $11M | $-24M | $-25.4K | |
| Stock Issued | $8M | $19M | $13M | $18M | $41M | $18M | $15M | $0 | $299.6K | $0 | · | · | |
| Net Stock Activity | $8M | $19M | $13M | $18M | $41M | $18M | · | $0 | · | · | · | · | |
| Financing Cash Flow | $238M | $26M | $56M | $18M | $42M | $40M | $26M | $29M | $21M | $7M | $44M | $8M | |
| Net Change in Cash | $105M | $-3M | $448.4K | $-10M | $11M | $26M | $-1M | $7M | $2M | $-4M | $7M | $2M | |
| Taxes Paid | $62.0K | $6.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $173M | $-51M | $-39M | $-25M | $-23M | $-22M | $-15M | $-24M | · | $-22M | · | $-6M | |
| Levered FCF | · | · | · | $-25M | $-23M | $-22M | $-16M | · | · | · | · | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 88.5% | 92.7% | · | 94.3% | 22.0% | 14.4% | -31.8% | 7.7% | · | -63.6% | · | -135.5% | |
| Operating Margin | 48.2% | -51.4% | · | -46819.9% | -15417.5% | -11378.4% | -7416.3% | -6250.4% | · | -11048.8% | · | -4703.3% | |
| Net Margin | 52.3% | -41.2% | · | -45409.9% | -14774.7% | -9207.7% | -5801.3% | -6242.4% | · | -10996.5% | · | -10806.2% | |
| Pretax Margin | 48.1% | -44.5% | · | -46305.2% | -15429.5% | -11368.5% | -7587.9% | -6242.4% | · | -10996.5% | · | -10806.2% | |
| EBITDA Margin | 48.2% | -51.4% | · | -46819.9% | -15417.5% | -11378.4% | -7416.3% | -6250.4% | · | -11048.8% | · | -4703.3% | |
| ROA | 34.5% | -17.8% | -64.3% | -45.4% | -47.7% | -55.9% | -68.0% | -166.2% | · | -83.5% | · | -507.2% | |
| ROE | 52.1% | -25.0% | -60.4% | -53.3% | -42.7% | -70.2% | -62.8% | 1175.9% | · | -95.1% | · | 10546.5% | |
| ROIC | 40.3% | -24.5% | · | -54.5% | -44.9% | -49.9% | -67.9% | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 3.4 | 7.0 | 9.4 | 12.4 | 11.6 | 5.0 | 2.4 | · | 5.3 | · | 3.5 | |
| Quick Ratio | 1.8 | 3.1 | 6.7 | 9.3 | 12.2 | 11.1 | 4.9 | 2.3 | · | 4.9 | · | 3.1 | |
| Interest Coverage | · | · | -1427.5 | -1155.0 | -1846.4 | -819.3 | -26.7 | -14342.9 | · | -18887.0 | · | -4265.5 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.4 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | · | 0.0 | |
| Inventory Turnover | 1.2 | 0.7 | · | · | 2.0 | 0.8 | 1.0 | 0.8 | · | -1.3 | · | -1.6 | |
| Receivables Turnover | 2.8 | 1.7 | · | · | · | · | · | 11.5 | · | 1.4 | · | 4.6 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.11 | $1.31 | $1.28 | $1.29 | $1.65 | $1.32 | $0.92 | $0.05 | · | $0.44 | · | $0.16 | |
| Revenue / Share | $3881.42 | $0.74 | · | $0.00 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $2179.68 | $-0.86 | $-0.75 | $-0.60 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.83 | $0.63 | $0.79 | $1.01 | $1.40 | $1.25 | $0.64 | $0.16 | · | $0.20 | · | $0.19 | |
| EPS (TTM) | $2.04 | $-0.30 | $-0.91 | $-0.74 | $-0.75 | · | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 617.0% | · | · | -65.7% | -20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1582.8% | 510.6% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 319.8% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $312M | $43M | $73.8K | $65.4K | $190.9K | $239.2K | $283.3K | $429.8K | $329.3K | $224.1K | $210.1K | $189.3K | |
| Net Income TTM | $163M | $-18M | $-46M | $-30M | $-28M | $-22M | $-16M | $-27M | $-33M | $-25M | $-18M | $-20M | |
| Market Cap | $922M | $522M | $207M | $181M | $173M | $249M | $187M | $702M | · | $309M | · | $215M | |
| P/E | 5.7 | -27.0 | -4.1 | -5.7 | -6.1 | · | · | · | · | · | · | · | |
| P/S | 3.0 | 12.0 | 2799.2 | 2762.4 | 907.6 | 1042.2 | 659.6 | 1633.9 | · | 1380.2 | · | 1133.3 | |
| P/B | 2.3 | 6.2 | 2.9 | 3.3 | 2.8 | 5.6 | 7.9 | 142.3 | · | 17.4 | · | 59.0 | |
| P / Tangible Book | · | 6.3 | 2.9 | 3.3 | 2.8 | 5.6 | · | · | · | · | · | · | |
| P / Cash Flow | 5.3 | -10.3 | -5.4 | -7.4 | -8.2 | -11.4 | -12.4 | -29.6 | · | -13.9 | · | -33.9 | |
| P / FCF | 5.3 | -10.3 | -5.3 | -7.4 | -7.7 | -11.3 | -12.4 | -29.6 | · | -13.9 | · | -33.8 | |
| Earnings Yield | 17.5% | -3.7% | -24.2% | -17.5% | -16.5% | · | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $102M | $127M | $129M | $104M | $40M | $39M | $31M | $11M | $806.1K | · | · | · | · | · | $29.7K | $6.8K | |
| Cost of Revenue | · | $12M | $11M | $8M | $2M | $2M | $1M | $634.6K | $509.8K | $818.5K | · | · | · | · | $406 | $1.5K | |
| Gross Profit | $77M | $105M | $107M | $93M | $38M | $37M | $30M | $11M | $296.3K | $-818.5K | · | · | · | · | $29.3K | $5.3K | |
| R&D Expense | $7M | $7M | $9M | $5M | $2M | $3M | $2M | $727.1K | $651.0K | $837.4K | $2M | $3M | $5M | $3M | $3M | $2M | |
| SG&A Expense | $15M | $22M | $24M | $25M | $10M | $10M | $7M | $7M | $8M | $9M | $3M | $4M | $4M | $8M | $6M | $5M | |
| Operating Expenses | $34M | $41M | $48M | $42M | $18M | $17M | $17M | $14M | $16M | $16M | $16M | $10M | $12M | $11M | $8M | $7M | |
| Operating Income | $43M | $64M | $59M | $51M | $20M | $20M | $13M | $-3M | $-15M | $-17M | $-16M | $-10M | $-12M | $-11M | $-8M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6.6K | $9.8K | · | $13.1K | $5.9K | $8.8K | $8.8K | $8.8K | |
| Interest Income | · | · | $890.0K | $2M | $828.9K | $566.8K | $510.6K | $553.9K | $657.4K | $857.2K | $920.0K | $765.2K | · | · | · | $93.4K | |
| Other Non-op | $-4M | $-8M | $-3M | $1M | $806.0K | $519.0K | $527.8K | $510.5K | $1M | $843.3K | $914.7K | $722.9K | $531.0K | $450.0K | $180.3K | $108.2K | |
| Pretax Income | $39M | $56M | $56M | $53M | $20M | $21M | $13M | $-3M | $-14M | $-16M | $-15M | $-10M | $-11M | $-11M | · | $-7M | |
| Income Tax | $13M | $17M | $42M | $-56M | $522.0K | $0 | $-230 | · | · | $-1M | · | · | · | · | $0 | · | |
| Net Income | $26M | $39M | $14M | $109M | $20M | $21M | $13M | $-3M | $-14M | $-14M | $-15M | $-10M | $-11M | $-11M | $-8M | $-7M | |
| EPS (Basic) | $0.33 | $0.48 | $0.22 | $1.42 | $0.29 | $0.32 | $0.25 | $-0.05 | $-0.25 | $-0.25 | $-0.25 | $-0.17 | $-0.25 | $-0.24 | $-0.20 | $-0.17 | |
| EPS (Diluted) | $0.29 | $0.43 | $0.20 | $1.26 | $0.28 | $0.30 | $0.25 | $-0.05 | $-0.25 | $-0.25 | $-0.25 | $-0.17 | $-0.25 | $-0.24 | $-0.20 | $-0.17 | |
| Shares (Basic) | 78,444,000 | 79,509,000 | · | 75,930,243 | 67,928,000 | 65,244,000 | · | 58,825,221 | 57,620,974 | 57,503,154 | · | 56,553,174 | 45,365,635 | 44,090,998 | · | 41,183,585 | |
| Shares (Diluted) | 92,479,000 | 92,985,000 | · | 86,214,170 | 71,919,000 | 68,975,000 | · | 58,825,221 | 57,620,974 | 57,503,154 | · | 56,553,174 | 45,365,635 | 44,090,998 | · | 41,183,585 | |
| EBITDA | $43M | $74M | · | $51M | $20M | $20M | · | $-3M | $-15M | $-17M | · | $-10M | $-12M | $-11M | · | $-7M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $257M | $178M | $145M | $48M | $159M | $66M | $41M | $35M | $29M | $35M | $44M | $53M | $20M | $25M | $43M | $43M | |
| Short-term Investments | $0 | $0 | $4M | $7M | $31M | $11M | $11M | $11M | $17M | $23M | $32M | $33M | $33M | $30M | $16M | $16M | |
| Receivables | $161M | $155M | $171M | $159M | $43M | $55M | $52M | $17M | $206.3K | · | · | · | · | · | · | · | |
| Inventory | $39M | $31M | $30M | $29M | $10M | $7M | $8M | $7M | $4M | $2M | $2M | · | · | · | · | $269 | |
| Prepaid Expense | $24M | $19M | $18M | $16M | $5M | $5M | $4M | $3M | $3M | $2M | $882.2K | $1M | $881.8K | $1M | $623.7K | $530.9K | |
| Current Assets | $481M | $383M | $367M | $260M | $248M | $145M | $115M | $73M | $53M | $63M | $79M | $89M | $55M | $57M | $60M | $60M | |
| PP&E (Net) | $8M | $6M | $6M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $521.0K | · | · | · | · | · | |
| Goodwill | $30M | $30M | $30M | $18M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $358M | $369M | $379M | $390M | $2M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Total Assets | $904M | $816M | $826M | $751M | $253M | $150M | $119M | $78M | $58M | $68M | $82M | $91M | $57M | $59M | $62M | $62M | |
| Accounts Payable | $10M | $13M | $8M | $20M | $6M | $2M | $2M | $1M | $3M | $3M | $4M | $2M | $3M | $1M | $2M | $2M | |
| Accrued Liabilities | $173M | $113M | $162M | $109M | $26M | $32M | $32M | $17M | $8M | $7M | $7M | $5M | $4M | $3M | $4M | $3M | |
| Current Liabilities | $187M | $129M | $174M | $134M | $32M | $34M | $34M | $18M | $11M | $10M | $11M | $8M | $7M | $5M | $6M | $5M | |
| Capital Leases | · | · | $2M | $2M | $258.1K | $304.1K | $349.0K | $393.0K | $435.2K | $476.6K | $517.0K | $556.4K | $594.3K | $631.4K | $667.6K | $702.9K | |
| Deferred Tax | $663.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $443M | $379M | $421M | $377M | $32M | $35M | $34M | $19M | $12M | $10M | $12M | $8M | $8M | $5M | $7M | $6M | |
| Common Stock | $78.0K | $78.0K | $79.0K | $78.3K | $74.6K | $67.7K | $64.0K | $57.9K | $55.3K | $55.0K | $54.9K | $54.8K | $45.8K | $44.5K | $42.8K | $41.2K | |
| Paid-in Capital | $573M | $575M | $582M | $565M | $520M | $434M | $424M | $412M | $396M | $394M | $392M | $390M | $346M | $340M | $330M | $323M | |
| Retained Earnings | $-112M | $-138M | $-177M | $-191M | $-299M | $-319M | $-340M | $-353M | $-350M | $-336M | $-322M | $-307M | $-297M | $-286M | $-275M | $-267M | |
| AOCI | $2.0K | $2.0K | $3.0K | $87.6K | $79.4K | $84.6K | $91.0K | $89.1K | $85.7K | $83.5K | $94.1K | $84.4K | $90.7K | $101.2K | $82.7K | $45.8K | |
| Stockholders' Equity | $461M | $437M | $405M | $374M | $221M | $115M | $85M | $59M | $46M | $58M | $70M | $83M | $49M | $54M | $55M | $56M | |
| Liabilities + Equity | $904M | $816M | $826M | $751M | $253M | $150M | $119M | $78M | $58M | $68M | $82M | $91M | $57M | $59M | $62M | $62M | |
| Shares Outstanding | 77,667,011 | 78,395,299 | 79,260,667 | 78,349,057 | 74,620,742 | 67,711,098 | 64,411,295 | 57,887,149 | 55,274,791 | 54,959,270 | 54,938,258 | 54,812,042 | 45,805,283 | 44,499,788 | 42,815,196 | 41,208,210 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $11M | · | · | $163.0K | $162.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $4M | $5M | $4M | $4M | $3M | $4M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $874.1K | $983.5K | |
| Deferred Tax | $4M | $13M | $34M | $-60M | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $10M | $4M | $51.9K | $51.9K | $52.1K | $51.9K | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-24M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $86M | $42M | $94M | $31M | $30M | $20M | $-6M | $-14M | $-14M | $-17M | $-11M | $-9M | $-9M | $-10M | $-6M | $-6M | |
| CapEx | $561.0K | $729.0K | $2M | $505.8K | $23.9K | $10.0K | $10.1K | $9.8K | $34.8K | $61.3K | $295.9K | $10.2K | $6.4K | $14.8K | $128.8K | $76.4K | |
| Investing Cash Flow | $-561.0K | $3M | $3M | $-291M | $-20M | $-195.0K | $-303.9K | $6M | $6M | $9M | $597.8K | $-586.9K | $-2M | $-15M | $-1.9K | $-114.3K | |
| Stock Issued | $0 | $0 | $1M | $0 | $0 | $7M | $6M | $12M | · | · | $433.9K | $0 | $5M | $7M | $6M | $300.0K | |
| Stock Repurchased | $6M | $11M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-11M | · | · | · | $7M | · | · | · | · | · | · | · | $7M | · | · | |
| Financing Cash Flow | $-7M | $-12M | $-1M | $151M | $83M | $6M | $11M | $14M | $1M | $-97.1K | $467.6K | $43M | $5M | $7M | $6M | $437.3K | |
| Net Change in Cash | $79M | $33M | $96M | $-110M | $93M | $26M | $5M | $7M | $-7M | $-8M | $-10M | $34M | $-6M | $-18M | $-95.3K | $-6M | |
| Free Cash Flow | · | $42M | · | · | · | $20M | · | · | · | $-17M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-17M | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.7% | 82.5% | · | 89.3% | 95.3% | 95.9% | · | 94.0% | 36.8% | · | · | · | · | · | · | 78.5% | |
| Operating Margin | 42.1% | 50.0% | · | 49.2% | 49.2% | 51.5% | · | -28.7% | -1898.1% | · | · | · | · | · | · | -102126.1% | |
| Net Margin | 25.5% | 30.3% | · | 104.1% | 49.9% | 52.8% | · | -24.2% | -1755.5% | · | · | · | · | · | · | -100538.7% | |
| Pretax Margin | 38.0% | 43.7% | · | 50.4% | 51.2% | 52.8% | · | -24.2% | -1755.5% | · | · | · | · | · | · | -100538.7% | |
| EBITDA Margin | 42.1% | 58.2% | · | 49.2% | 49.2% | 51.5% | · | -28.7% | -1898.1% | · | · | · | · | · | · | -102126.1% | |
| ROA | 4.5% | 8.0% | · | 26.2% | 12.8% | 19.0% | · | -3.3% | -24.7% | -22.7% | · | -12.7% | -18.1% | -17.0% | · | -10.0% | |
| ROE | 7.6% | 14.0% | · | 50.2% | 14.9% | 23.9% | · | -3.9% | -29.7% | -25.9% | · | -14.0% | -20.3% | -18.6% | · | -10.9% | |
| ROIC | 6.2% | 10.1% | · | 28.3% | 8.6% | · | · | · | · | -26.3% | · | · | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.0 | · | 1.9 | 7.8 | 4.2 | · | 4.0 | 4.8 | 6.7 | · | 11.6 | 7.4 | 12.1 | · | 11.8 | |
| Quick Ratio | 2.2 | 2.6 | · | 1.6 | 7.4 | 3.8 | · | 3.4 | 4.1 | 6.1 | · | 11.3 | 7.1 | 11.9 | · | 11.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -2333.9 | -1698.4 | · | -798.2 | -2017.5 | -1255.4 | · | -793.3 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.1 | 0.0 | · | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.6 | · | 0.4 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.7 | · | · | · | · | · | 0.1 | |
| Receivables Turnover | 1.0 | 1.2 | · | 1.2 | 1.8 | 1.4 | · | 1.3 | 7.8 | · | · | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.93 | $5.57 | · | $4.78 | $2.96 | $1.70 | · | $1.01 | $0.84 | $1.06 | · | $1.52 | $1.07 | $1.21 | · | $1.37 | |
| Revenue / Share | $1.10 | $1.37 | · | $1.21 | $0.55 | $0.57 | · | $0.19 | $0.01 | · | · | · | · | · | · | $0.00 | |
| Cash Flow / Share | · | $0.46 | · | · | · | $0.29 | · | · | · | $-0.30 | · | · | · | $-0.24 | · | · | |
| Cash / Share | $3.31 | $2.27 | · | $0.62 | $2.13 | $0.98 | · | $0.61 | $0.52 | $0.64 | · | $0.97 | $0.43 | $0.57 | · | $1.05 | |
| EPS (TTM) | $2.18 | $2.17 | · | $2.09 | $0.78 | $0.25 | · | $-0.80 | $-0.92 | $-0.92 | · | $-0.86 | $-0.86 | $-0.80 | · | $-0.75 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $462M | $400M | · | $214M | $121M | $83M | · | · | · | $65.4K | · | $65.4K | $65.4K | $65.4K | · | $92.1K | |
| Net Income TTM | $187M | $181M | · | $162M | $51M | $17M | · | $-46M | $-53M | $-50M | · | $-40M | $-37M | $-33M | · | $-29M | |
| Market Cap | $610M | $532M | · | $911M | $919M | $417M | · | $468M | $239M | $233M | · | $203M | $182M | $184M | · | $117M | |
| P/E | 3.6 | 3.1 | · | 5.6 | 15.8 | 24.6 | · | -10.1 | -4.7 | -4.6 | · | -4.3 | -4.6 | -5.2 | · | -3.8 | |
| P/S | 1.3 | 1.3 | · | 4.3 | 7.6 | 5.1 | · | · | · | 3562.7 | · | 3100.6 | 2780.2 | 2816.6 | · | 1266.2 | |
| P/B | 1.3 | 1.2 | · | 2.4 | 4.2 | 3.6 | · | 8.0 | 5.2 | 4.0 | · | 2.4 | 3.7 | 3.4 | · | 2.1 | |
| P / Tangible Book | 8.4 | 13.9 | · | · | 4.2 | 3.7 | · | 8.2 | 5.2 | 4.0 | · | 2.4 | 3.7 | 3.4 | · | 2.1 | |
| P / Cash Flow | · | 12.6 | · | · | · | 21.1 | · | · | · | -13.5 | · | · | · | -17.7 | · | · | |
| Earnings Yield | 27.8% | 32.0% | · | 18.0% | 6.3% | 4.1% | · | -9.9% | -21.2% | -21.7% | · | -23.2% | -21.7% | -19.3% | · | -26.5% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $312M | $43M | · | $65.4K | $190.9K |
| Margine Lordo % | 88.5% | 92.7% | · | 94.3% | 22.0% |
| Margine Operativo % | 48.2% | -51.4% | · | -46819.9% | -15417.5% |
| Utile netto | $163M | $-18M | $-46M | $-30M | $-28M |
| EPS Diluito | $2.04 | $-0.30 | $-0.91 | $-0.74 | $-0.75 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 2.1 | 3.4 | 7.0 | 9.4 | 12.4 |
| Quick Ratio | 1.8 | 3.1 | 6.7 | 9.3 | 12.2 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $173M | $-51M | $-39M | $-25M | $-23M |
Proprietari istituzionali (13F) 211 filer · $401.3M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
211
Valore detenuto
$401.3M
Nuove posizioni
27
Posizioni chiuse
22
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 27 (-26 vs trimestre precedente) | 22 (-23 vs trimestre precedente) | 68 (+11 vs trimestre precedente) | 61 (+3 vs trimestre precedente) | +1.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $52.323.486 | 4.499.010 | 13,04% | Azioni |
| BlackRock, Inc. | $49.644.269 | 6.324.111 | 12,37% | Azioni |
| Deep Track Capital, LP | $49.251.497 | 6.274.076 | 12,27% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.610.339 | 3.135.075 | 6,13% | Azioni |
| STATE STREET CORP | $18.187.233 | 2.316.845 | 4,53% | Azioni |
| ROYCE & ASSOCIATES LP | $17.084.442 | 2.176.362 | 4,26% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $15.286.964 | 1.947.014 | 3,81% | Azioni |
| UBS Group AG | $14.741.829 | 1.877.940 | 3,67% | Azioni |
| OBERWEIS ASSET MANAGEMENT INC/ | $10.392.733 | 1.323.915 | 2,59% | Azioni |
| Alyeska Investment Group, L.P. | $6.672.500 | 850.000 | 1,66% | Azioni |
| MARSHALL WACE, LLP | $6.119.350 | 779.535 | 1,52% | Azioni |
| NORTHERN TRUST CORP | $5.937.976 | 756.430 | 1,48% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5.562.541 | 708.604 | 1,39% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.190.420 | 661.200 | 1,29% | Opzione Call |
| Trexquant Investment LP | $4.896.806 | 623.797 | 1,22% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.852.650 | 618.172 | 1,21% | Azioni |
| ARMISTICE CAPITAL, LLC | $3.925.000 | 500.000 | 0,98% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $3.801.928 | 484.322 | 0,95% | Azioni |
| GOLDMAN SACHS GROUP INC | $3.661.185 | 466.393 | 0,91% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $3.502.216 | 446.142 | 0,87% | Azioni |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $3.407.936 | 434.132 | 0,85% | Azioni |
| Palisades Investment Partners, LLC | $3.348.363 | 426.543 | 0,83% | Azioni |
| MORGAN STANLEY | $3.323.231 | 423.341 | 0,83% | Azioni |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.291.379 | 419.284 | 0,82% | Azioni |
| Private Advisor Group, LLC | $3.260.962 | 415.406 | 0,81% | Azioni |
| Bank of New York Mellon Corp | $3.107.871 | 395.907 | 0,77% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.935.115 | 373.900 | 0,73% | Opzione Put |
| AMERICAN CENTURY COMPANIES INC | $2.710.927 | 345.341 | 0,68% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.503.899 | 318.968 | 0,62% | Azioni |
| AMERIPRISE FINANCIAL INC | $2.168.853 | 276.287 | 0,54% | Azioni |
| Brandywine Global Investment Management, LLC | $2.093.167 | 179.980 | 0,52% | Azioni |
| Empowered Funds, LLC | $1.909.371 | 243.232 | 0,48% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.905.862 | 242.785 | 0,47% | Azioni |
| Steward Partners Investment Advisory, LLC | $1.826.028 | 232.615 | 0,46% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $1.693.990 | 215.795 | 0,42% | Azioni |
| COMMONWEALTH EQUITY SERVICES, LLC | $1.686.650 | 214.860 | 0,42% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $1.661.233 | 211.622 | 0,41% | Azioni |
| Squarepoint Ops LLC | $1.627.917 | 207.378 | 0,41% | Azioni |
| CITADEL ADVISORS LLC | $1.612.390 | 205.400 | 0,40% | Opzione Call |
| Balyasny Asset Management L.P. | $1.588.605 | 202.370 | 0,40% | Azioni |
| PRINCIPAL FINANCIAL GROUP INC | $1.498.887 | 190.941 | 0,37% | Azioni |
| Nuveen, LLC | $1.454.401 | 185.274 | 0,36% | Azioni |
| Jump Financial, LLC | $1.413.212 | 180.027 | 0,35% | Azioni |
| D. E. Shaw & Co., Inc. | $1.348.685 | 171.807 | 0,34% | Azioni |
| JANE STREET GROUP, LLC | $1.326.650 | 169.000 | 0,33% | Opzione Call |
| DIADEMA PARTNERS LP | $1.314.875 | 167.500 | 0,33% | Opzione Put |
| AQR CAPITAL MANAGEMENT LLC | $1.188.765 | 151.435 | 0,30% | Azioni |
| BANK OF AMERICA CORP /DE/ | $1.182.650 | 150.656 | 0,29% | Azioni |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1.167.079 | 171.882 | 0,29% | Azioni |
| JANE STREET GROUP, LLC | $1.139.396 | 145.146 | 0,28% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| CorMedix Inc. | 12 Settembre 2025 | 19,95% | Deposito iniziale | Investimento passivo | SEC |
| Elliott Investment Management L.P. ×2 depositi | 11 Febbraio 2021 | · | Deposito iniziale | · | SEC |
| Elliott Associates, L.P., Elliott International, L.P., Elliott International Capital Advisors Inc. ×10 depositi | 10 Settembre 2019 | · | Deposito iniziale | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 39 insider · 18 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joseph Todisco | Chief Executive Officer | 04 Febbraio 2026 A | 774.749 | 0 | 1 | $-360.000 |
| Khoso Baluch | Chief Executive Officer | 11 Gennaio 2021 A | 60.905 | 0 | 0 | $0 |
| John C. Houghton | President and CEO | 18 Agosto 2010 P | 17.328 | 0 | 0 | $0 |
| Susan Blum | Chief Financial Officer | 29 Agosto 2026 F | 124.315 | 0 | 0 | $0 |
| Matthew T David | Chief Financial Officer | 10 Gennaio 2025 F | 95.270 | 0 | 0 | $0 |
| Robert W. Cook | Chief Financial Officer | 30 Settembre 2019 P | 27.517 | 0 | 0 | $0 |
| Harry O'Grady | Chief Financial Officer | 21 Luglio 2014 A | · | 0 | 0 | $0 |
| Brian Lenz | COO, CFO, Treasurer and Secretary | 20 Marzo 2012 A | 17.000 | 0 | 0 | $0 |
| Elizabeth Hurlburt | Chief Operating Officer | 29 Agosto 2026 F | 270.463 | 0 | 0 | $0 |
| Kaufman Beth Zelnick | Chief Legal Officer | 29 Agosto 2026 F | 260.684 | 0 | 0 | $0 |
| Michael David Seckler | Chief Commercial Officer | 08 Gennaio 2026 A | 133.156 | 0 | 0 | $0 |
| Erin Mistry | EVP, Chief Commercial Officer | 10 Gennaio 2025 F | 100.992 | 0 | 0 | $0 |
| Phoebe Mounts | General Counsel | 14 Gennaio 2023 A | 7.200 | 0 | 0 | $0 |
| Thomas Nusbickel | EVP, Chief Commercial Officer | 18 Febbraio 2022 A | · | 0 | 0 | $0 |
| Jr. John L. Armstrong | Exec VP of Tech Operations | 11 Gennaio 2021 A | 96.878 | 0 | 0 | $0 |
| Richard Cohen | Chief Financial Officder | 20 Marzo 2013 A | · | 0 | 0 | $0 |
| Mark A. Klausner | Chief Medical Officer | 01 Marzo 2011 A | · | 0 | 0 | $0 |
| Mark T. Houser | Chief Medical Officer | 26 Novembre 2010 P | 52.832 | 0 | 0 | $0 |
| Janet Dillione | Direttore | 18 Settembre 2026 M | 117.835 | 0 | 5 | $-1.547.556 |
| Gregory Scott Duncan | Direttore | 26 Gennaio 2026 A | 68.786 | 0 | 0 | $0 |
| Myron Kaplan | Direttore | 26 Gennaio 2026 A | 231.487 | 1 | 0 | $275.500 |
| Robert A Stewart | Direttore | 26 Gennaio 2026 A | 66.453 | 0 | 0 | $0 |
| Steven W Lefkowitz | Direttore | 26 Gennaio 2026 A | 125.951 | 0 | 1 | $-475.200 |
| Alan W Dunton | Direttore | 26 Gennaio 2026 A | 70.703 | 0 | 1 | $-260.000 |
| Paulo F Costa | Direttore | 17 Maggio 2023 P | 10.000 | 0 | 0 | $0 |
| Mehmood Khan | Direttore | 19 Agosto 2020 P | 178.767 | 0 | 0 | $0 |
| Gary A. Gelbfish | Direttore | 10 Gennaio 2019 A | 2.654.871 | 0 | 0 | $0 |
| Matthew Duffy | Direttore | 03 Giugno 2016 S | 28.571 | 0 | 0 | $0 |
| Timothy M Hofer | Direttore | 06 Gennaio 2012 A | 8.425 | 0 | 0 | $0 |
| James Lefkowitz | Direttore | 15 Dicembre 2011 P | 40.272 | 0 | 0 | $0 |
| Bami Bastani | Direttore | 14 Gennaio 2011 A | · | 0 | 0 | $0 |
| Russell H Ellison | Direttore | 30 Marzo 2010 P | 160.000 | 0 | 0 | $0 |
| PHARMABIO DEVELOPMENT INC | Proprietario del 10% | 12 Aprile 2012 S | 778.563 | 0 | 0 | $0 |
| Cora M Tellez | · | 30 Maggio 2017 P | 182.371 | 0 | 0 | $0 |
| Taunia Markvicka | · | 15 Maggio 2017 P | 37.100 | 0 | 0 | $0 |
| Michael W George | · | 15 Maggio 2017 A | 10.000 | 0 | 0 | $0 |
| Antony Pfaffle | · | 07 Febbraio 2017 M | 0 | 0 | 0 | $0 |
| Judith R Abrams | · | 30 Gennaio 2017 A | · | 0 | 0 | $0 |
| Randy Milby | · | 09 Agosto 2016 M | 246.243 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 19 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0,72% | 19.753 NS | 31 Luglio 2026 | N-PORT |
| IWC · iShares Trust | 0,14% | 252.715 SH | 11 Settembre 2026 | Giornaliero |
| IHE · iShares Trust | 0,13% | 270.547 SH | 11 Settembre 2026 | Giornaliero |
| CALF · Pacer Funds Trust | 0,13% | 626.124 NS | 31 Luglio 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 64.851 SH | 19 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 5.513 SH | 02 Ottobre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 429.102 SH | 19 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | 0,02% | 1.903.709 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,02% | 35.613 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 834.960 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 208.109 SH | 19 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 31.479 NS | 31 Luglio 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.922 SH | 02 Ottobre 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 4.449 SH | 11 Settembre 2026 | Giornaliero |
| IWV · iShares Trust | 0,00% | 23.056 SH | 09 Settembre 2026 | Giornaliero |
| ITOT · iShares Trust | 0,00% | 101.060 SH | 11 Settembre 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.227.723 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.542 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 699.130 SH | 11 Settembre 2026 | Giornaliero |
CRMD Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 11 analisti
COMPRA
Target mediano
$15.00
+108,6%
3 27,3%
Acquisto forte
7 63,6%
Compra
1 9,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
6 analisti · 2026-09-29Target medio $15.33 +113,3%
← Sotto tutti i target
Prezzo attuale $7.19
Basso$13.00
Media$15.33
Alto$19.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | · |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026